Episode 330 - Zan Fleming - Founder and Executive Chairman of Kinexum

In this episode of the Diabetes Innovators Series, the conversation
explores the evolution of diabetes treatment, the challenges faced in
managing diabetes today, and the future of diabetes research. Zan, an
endocrinologist and former FDA executive and Founder and executive chairman
of Kinexum, shares insights from his career, including the historical
context of diabetes management, the importance of A1C as a marker, and the
potential of new treatments like GLP-1 agonists. The discussion also
touches on the concept of meta-abesity, the shared root causes of chronic
diseases, and the need for a focus on health span rather than just
lifespan.

Chapters

00:00 Introduction to Diabetes Innovation Series

03:06 Zan's Journey in Diabetes Research

06:05 Transforming Diabetes Treatment: A Historical Perspective

09:00 The Evolution of Diabetes Management Tools

11:42 Challenges in Diabetes Management Today

14:41 The Future of Diabetes Treatment: Aiming for a Cure

17:57 Understanding the Drug Approval Process

20:32 Meta-Abesity: A New Perspective on Chronic Diseases

23:48 Innovations in Longevity and Health Span

26:27 The Role of GLP-1 Agonists in Diabetes Management

29:29 Future Directions in Diabetes Research

32:29 Memorable Moments in Drug Proposals

35:37 Conclusion and Future Collaborations

Resources:

Kinexum

Zan Fleming